U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. FDA Crowdsourcing
  1. Center for Drug Evaluation and Research (CDER)

FDA Crowdsourcing

What is crowdsourcing?

Crowdsourcing is the practice of asking the public for ideas, information, and opinions to help solve a problem in an innovative way or streamline an intricate process for an organization. 

Crowdsourcing allows us to engage with patients, caregivers, researchers, drug manufacturers, healthcare providers, and other stakeholders to get diverse ideas, thoughts, or comments on various topics.

While crowdsourcing aims to generate new ideas, stakeholders may suggest ideas the FDA has previously implemented, providing the FDA an opportunity to educate the public about those actions.

Our external crowdsourcing platform, ShareYourVoice, is where we'll seek your response on various topics.

Here's how it works

  1. We ask you questions on an active topic related to our mission and you post your ideas. 
  2. Anyone interested in the topic can comment on those posts, building upon the original thoughts and/or ask follow-up questions.
  3. We review the posts and determine the best way to incorporate your feedback into our work.

Why you should participate in crowdsourcing

  • Lets us hear your voice.
  • Provides new information about FDA initiatives.
  • Generates ideas for us to consider that we may incorporate in the future. 

Become a participant

Visit our crowdsourcing platform ShareYourVoice to create an account and make your voice heard.

Frequently asked questions

We've answered some of the questions that you may have. If you don't see what's on your mind, reach out to us anytime.

Past crowdsourcing examples

Office Objective Audience

Patient-Focused Drug Development Program

Supplement the Voice-of-the-Patient report by adding a broader range of voices to those captured at a PFDD public meeting.

Patients, caregivers, and others in the vitiligo community.

Oncology Center of Excellence

Develop a list of research topics for FDA that makes best use of proprietary, in-house patient data.

Academics, researchers, and industry members.

Center for Drug Evaluation and Research

Develop a list of research topics for FDA that makes best use of proprietary, in-house patient data.

Patients, caregivers, and advocates from the Progressive Multifocal Leukoencephalopathy community.

CDER Office of Communications

Connect with public stakeholders and determine the best ways to communicate with them, particularly as it relates to CDER-regulated drug products. This includes understanding the best channels to reach stakeholders and the type of information those stakeholders are seeking.

General public.
Back to Top